NR3C1 and glioblastoma: The top Canonical Pathways affected by SCLC treatment were Molecular Mechanisms of Cancer, Glioblastoma Multiforme Signaling, Glioblastoma Signaling, PI3K/AKT Signaling, and Glucocorticoid Receptor Signaling.